181 related articles for article (PubMed ID: 29223698)
1. Risk Factors for Unsuccessful Office-Based Endometrial Biopsy: A Comparative Study of Office-Based Endometrial Biopsy (Pipelle) and Diagnostic Dilation and Curettage.
Xie B; Qian C; Yang B; Ning C; Yao X; Du Y; Shi Y; Luo X; Chen X
J Minim Invasive Gynecol; 2018; 25(4):724-729. PubMed ID: 29223698
[TBL] [Abstract][Full Text] [Related]
2. Comparison the Diagnostic Value of Dilatation and Curettage Versus Endometrial Biopsy by Pipelle--a Clinical Trial.
Sanam M; Majid MM
Asian Pac J Cancer Prev; 2015; 16(12):4971-5. PubMed ID: 26163624
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the success of histopathological diagnosis with dilatation-curettage and Pipelle endometrial sampling.
Kazandi M; Okmen F; Ergenoglu AM; Yeniel AO; Zeybek B; Zekioglu O; Ozdemir N
J Obstet Gynaecol; 2012 Nov; 32(8):790-4. PubMed ID: 23075358
[TBL] [Abstract][Full Text] [Related]
4. [Different methods for the diagnosis of endometrial histological comparative study].
Leng X; Wang M; Zhang SL; Wang D; Cao W; Yang XH
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):891-5. PubMed ID: 24495679
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the histopathological diagnoses of preoperative dilatation and curettage and Pipelle biopsy.
Gungorduk K; Asicioglu O; Ertas IE; Ozdemir IA; Ulker MM; Yildirim G; Ataser G; Sanci M
Eur J Gynaecol Oncol; 2014; 35(5):539-43. PubMed ID: 25423700
[TBL] [Abstract][Full Text] [Related]
6. Which is the best technique for endometrial sampling? Aspiration (pipelle) versus dilatation and curettage (D&C).
Demirkiran F; Yavuz E; Erenel H; Bese T; Arvas M; Sanioglu C
Arch Gynecol Obstet; 2012 Nov; 286(5):1277-82. PubMed ID: 22766754
[TBL] [Abstract][Full Text] [Related]
7. Outpatient endometrial biopsy with Pipelle vs diagnostic dilatation and curettage.
Rauf R; Shaheen A; Sadia S; Waqar F; Zafar S; Sultana S; Waseem S
J Ayub Med Coll Abbottabad; 2014; 26(2):145-8. PubMed ID: 25603664
[TBL] [Abstract][Full Text] [Related]
8. Outpatient endometrial sampling with the Pipelle curette.
Ben-Baruch G; Seidman DS; Schiff E; Moran O; Menczer J
Gynecol Obstet Invest; 1994; 37(4):260-2. PubMed ID: 8050731
[TBL] [Abstract][Full Text] [Related]
9. Pipelle biopsy and dilatation and curettage in clinical practice: are factors affecting their effectiveness the same?
Piatek S; Warzecha D; Kisielewski F; Szymusik I; Panek G; Wielgos M
J Obstet Gynaecol Res; 2019 Mar; 45(3):645-651. PubMed ID: 30548369
[TBL] [Abstract][Full Text] [Related]
10. Correlation between pre-operative diagnosis and final pathological diagnosis of endometrial malignancies; impact on primary surgical treatment.
Laban M; Nassar S; Elsayed J; Hassanin AS
Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():100-105. PubMed ID: 34175583
[TBL] [Abstract][Full Text] [Related]
11. Validity of pipelle endometrial sampling in patients with abnormal uterine bleeding.
Fakhar S; Saeed G; Khan AH; Alam AY
Ann Saudi Med; 2008; 28(3):188-91. PubMed ID: 18500186
[TBL] [Abstract][Full Text] [Related]
12. Pipelle versus fractional curettage for the endometrial sampling in postmenopausal women.
Bunyavejchevin S; Triratanachat S; Kankeow K; Limpaphayom KK
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S326-30. PubMed ID: 11529353
[TBL] [Abstract][Full Text] [Related]
13. The role of Pipelle Mark II sampling in endometrial disease diagnosis.
Polena V; Mergui JL; Zerat L; Sananes S
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):233-7. PubMed ID: 17029754
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Pipelle sampler with conventional dilatation and curettage (D&C) for Chinese endometrial biopsy.
Liu H; Wang FL; Zhao YM; Yao YQ; Li YL
J Obstet Gynaecol; 2015; 35(5):508-11. PubMed ID: 25549755
[TBL] [Abstract][Full Text] [Related]
15. Endometrial sampling in low-risk patients with abnormal uterine bleeding: a systematic review and meta-synthesis.
Narice BF; Delaney B; Dickson JM
BMC Fam Pract; 2018 Jul; 19(1):135. PubMed ID: 30060741
[TBL] [Abstract][Full Text] [Related]
16. Pipelle endometrial sampling success rates in Kazakhstani settings: results from a prospective cohort analysis.
Terzic M; Aimagambetova G; Bapayeva G; Ukybassova T; Kenbayeva K; Kaiyrlykyzy A; Ibrayimov B; Lyasova A; Terzic S; Alkatout I; Gitas G; Hortu İ; Garzon S; Laganà AS
J Obstet Gynaecol; 2022 Jul; 42(5):1255-1260. PubMed ID: 34592892
[TBL] [Abstract][Full Text] [Related]
17. Patient and provider factors associated with endometrial Pipelle sampling failure.
Adambekov S; Goughnour SL; Mansuria S; Donnellan N; Elishaev E; Villanueva HJ; Edwards RP; Bovbjerg DH; Linkov F
Gynecol Oncol; 2017 Feb; 144(2):324-328. PubMed ID: 27912906
[TBL] [Abstract][Full Text] [Related]
18. Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.
Merisio C; Berretta R; De Ioris A; Pultrone DC; Rolla M; Giordano G; Tateo S; Melpignano M
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):107-11. PubMed ID: 16154046
[TBL] [Abstract][Full Text] [Related]
19. Is pipelle biopsy really adequate for diagnosing endometrial disease?
Tanriverdi HA; Barut A; Gün BD; Kaya E
Med Sci Monit; 2004 Jun; 10(6):CR271-4. PubMed ID: 15173672
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of biopsy strategies for endometrial cancer diagnosis in women with postmenopausal bleeding: Pipelle sampling curette versus dilatation & curettage.
Yi Y; Bryce CL; Adambekov S; Edwards RP; Goughnour SL; Linkov F
Gynecol Oncol; 2018 Jul; 150(1):112-118. PubMed ID: 29747864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
